Cellebrite DI Ltd.

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Net Income (Loss) ($1.9m) $5.8m $71.4m $120.8m ($81.1m) ($283.0m) $78.3m
Amortization of premium, discount and accrued interest on marketable securities $0 $0 ($372k) ($1.1m) ($2.9m) ($2.4m)
Depreciation and amortization $4.1m $5.9m $7.0m $9.2m $10.0m $10.6m $11.9m
Deferred tax assets, net ($1.7m) ($2.8m) ($1.6m) ($2.4m) $5.1m ($4.0m) $75k
Share-based compensation $12.8m $7.3m $6.5m $13.7m $19.0m $30.6m $44.9m
Changes in operating lease right-of-use assets $0 $0 $4.7m $4.4m $5.3m $4.6m
Changes in operating lease liabilities $0 $0 ($6.0m) ($4.2m) ($4.8m) $547k
Operating lease liabilities arising from obtaining right of use assets $0 $0 $4.4m $1.9m $11.2m
Disposal and write-off of property and equipment $0 $0 $554k
Abandonment of right‑of‑use assets and disposal of leasehold improvements $0 $0 $1.8m
Interest on deposits and investments $0 $0 ($684k) ($7.7m) ($10.7m) ($8.2m)
Remeasurement of Warrant liability $0 $0 ($12.0m) ($36.5m) $34.1m $110.7m $0
Remeasurement of Restricted Sponsor Shares liability $0 ($17.6m) ($27.2m) $29.7m $65.9m $0
Remeasurement of Price Adjustment Shares liability $0 ($38.3m) ($53.2m) $55.5m $173.1m $0
(Increase) decrease in trade receivables ($12.2m) ($19.7m) ($2.0m) ($12.9m) $2.3m ($5.8m) ($15.8m)
Increase in deferred revenues $15.8m $47.7m $21.8m $39.0m $46.1m $22.3m $49.8m
Increase in other non-current assets ($27k) ($339k) ($1.4m) $227k ($5.6m) ($341k) ($6.9m)
Decrease (increase) in prepaid expenses and other current assets ($3.1m) $335k ($8.3m) ($5.7m) ($9.2m) $3.2m $5.6m
Decrease in inventories $794k ($693k) ($1.8m) ($3.7m) $243k $982k $1.6m
Increase in trade payables $974k ($1.4m) $4.2m ($5.5m) $3.7m $2.8m $4.9m
Increase in other accounts payable and accrued expenses ($158k) $22.4m $5.1m ($8.9m) $734k $17.6m $4.2m
(Decrease) increase in other long-term liabilities $644k $1.4m $3.0m ($4.1m) $121k $880k ($2.0m)
Payments to Acquire Intangible Assets $0 $0 $3.0m ($2.2m) ($2.7m) ($2.0m) $0
Payments to Acquire Marketable Securities $0 $0 ($89.4m) ($55.3m) ($127.8m) ($321.2m)
Proceeds from maturity of marketable securities $0 $0 $22.3m $56.3m $60.0m $153.0m
Proceeds from sales of marketable securities $0 $0 $59.8m
Exercise of options $141k $1.5m $2.3m $12.6m $19.1m $17.3m $20.1m
Proceeds from Employee Share Purchase Plan $0 $0 $1.3m $2.6m $3.3m $5.0m
Exercise of public warrants $0 $0 $5k $0 $53k $0
Redemption of public warrants $0 $0 ($11k) $0
Reclass and release of Restricted Sponsor Share $0 $0 $113.1m $0
Reclassification and issuance of Price Adjustment Share $0 $0 $164.8m $0
Net Cash Provided by (Used in) Operating Activities, Total $16.1m $66.5m $36.1m $20.6m $102.1m $132.2m $173.5m
Payments to Acquire Property, Plant, and Equipment ($6.2m) ($6.2m) ($5.1m) ($6.9m) ($5.2m) ($8.6m) ($13.2m)
Payments to Acquire Businesses, Net of Cash Acquired $0 ($15.0m) ($20.0m) $0 $0 ($2.7m) ($147.5m)
Payments to Acquire Short-Term Investments ($138.5m) ($21.0m) ($76.0m) ($89.0m) ($207.0m) ($187.0m)
Proceeds from Sale of Short-Term Investments $153.3m $94.3m $60.9m $73.4m $138.7m $187.9m
Net Cash Provided by (Used in) Investing Activities, Total ($46.7m) ($6.4m) $45.2m ($91.2m) ($22.5m) ($149.5m) ($268.2m)
Net cash provided by financing activities $75.5m ($8.6m) ($68.4m) $14.0m $21.8m $20.7m $25.1m
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect, Total $44.9m $51.5m $12.9m ($56.7m) $101.3m $3.3m ($69.7m)
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation ($67k) $695k ($754k) ($1.6m) $589k ($1.2m) $2.5m
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning Balance $81.7m $133.8m $146.0m $87.6m $189.5m $191.7m $124.5m
Income Taxes Paid, Net $3.0m $2.9m $8.2m $9.1m $10.0m $7.7m ($549k)